US Stock MarketDetailed Quotes

PTCT PTC Therapeutics

Watchlist

43.880
-1.230-2.73%

Close Nov 29 13:00 ET

43.880
0.0000.00%

Post 17:01 ET

3.38BMarket Cap-7387P/E (TTM)

PTC Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

0.11%196.79M

-12.68%186.7M

-4.66%210.12M

34.20%937.82M

83.41%307.06M

-9.46%196.58M

29.17%213.81M

48.17%220.38M

29.75%698.8M

1.32%167.41M

Operating revenue

0.11%196.79M

-12.68%186.7M

-4.66%210.12M

34.20%937.82M

83.41%307.06M

-9.46%196.58M

29.17%213.81M

48.17%220.38M

29.75%698.8M

1.32%167.41M

Cost of revenue

14.27%10.85M

21.96%15.53M

4.21%14.74M

46.57%65.49M

167.31%29.12M

-32.25%9.49M

32.08%12.73M

39.56%14.14M

38.20%44.68M

16.79%10.89M

Gross profit

-0.61%185.94M

-14.87%171.18M

-5.27%195.38M

33.36%872.34M

77.57%277.94M

-7.89%187.08M

28.99%201.08M

48.80%206.24M

29.21%654.12M

0.40%156.52M

Operating expense

-21.68%237.9M

-36.42%204.53M

-25.05%240.93M

11.67%1.22B

-13.35%274.82M

9.81%303.75M

22.12%321.72M

35.74%321.45M

24.15%1.09B

25.50%317.18M

Selling and administrative expenses

-9.19%73.46M

-21.42%69.5M

-15.70%73.27M

2.01%332.54M

-17.72%76.29M

0.96%80.89M

10.71%88.45M

18.62%86.91M

14.08%326M

7.13%92.72M

Research and development costs

-1.71%161.41M

-28.89%132.17M

-40.48%116.13M

2.31%666.56M

-35.69%121.35M

-0.76%164.21M

18.19%185.87M

39.30%195.12M

20.49%651.5M

25.93%188.69M

Depreciation amortization depletion

-94.82%3.04M

-93.96%2.87M

30.74%51.53M

91.01%222.64M

115.79%77.17M

89.05%58.65M

80.26%47.4M

67.92%39.42M

112.88%116.55M

118.87%35.76M

-Depreciation and amortization

-94.82%3.04M

-93.96%2.87M

30.74%51.53M

91.01%222.64M

115.79%77.17M

89.05%58.65M

80.26%47.4M

67.92%39.42M

112.88%116.55M

118.87%35.76M

Operating profit

55.46%-51.97M

72.35%-33.36M

60.46%-45.55M

20.58%-349.4M

101.94%3.12M

-58.75%-116.66M

-12.16%-120.64M

-17.30%-115.22M

-17.33%-439.93M

-65.92%-160.66M

Net non-operating interest income expense

-47.76%-41.61M

-47.85%-43.49M

-49.41%-40.83M

-42.16%-129.18M

-80.71%-44.28M

-34.87%-28.16M

-33.85%-29.42M

-16.23%-27.33M

-5.64%-90.87M

-8.88%-24.5M

Non-operating interest expense

47.76%41.61M

47.85%43.49M

49.41%40.83M

42.16%129.18M

80.71%44.28M

34.87%28.16M

33.85%29.42M

16.23%27.33M

5.64%90.87M

8.88%24.5M

Other net income (expense)

79.71%-4.42M

89.84%-8.89M

-77.62%1.69M

-283.71%-217.53M

-2,455.03%-115.9M

33.72%-21.77M

-356.34%-87.42M

4,974.84%7.56M

1.19%-56.69M

76.47%-4.54M

Special income (charges)

-69.60%-2.54M

92.28%-6.86M

104.17%100K

-2,941.93%-227.66M

-239.83%-134.86M

-128.30%-1.5M

-684.87%-88.9M

-120.51%-2.4M

-1,596.80%-7.48M

-427.97%-39.68M

-Less：Restructuring and merger&acquisition

-53.33%700K

103.96%5.1M

-104.17%-100K

-393.05%-127.7M

-142.86%-2.7M

128.30%1.5M

-748.03%-128.9M

120.51%2.4M

-5,080.00%-25.9M

152.07%6.3M

-Less:Impairment of capital assets

--1.84M

-99.19%1.76M

----

552.41%217.8M

--0

--217.8M

----

--33.38M

-Less:Other special charges

----

--137.56M

----

Other non- operating income (expenses)

90.76%-1.87M

-236.92%-2.03M

-84.02%1.59M

120.59%10.13M

-46.05%18.96M

46.87%-20.27M

104.30%1.48M

183.98%9.96M

14.98%-49.21M

212.02%35.15M

Income before tax

41.18%-97.99M

63.90%-85.73M

37.26%-84.7M

-18.49%-696.11M

17.21%-157.05M

-30.96%-166.59M

-59.71%-237.48M

-10.75%-134.99M

-13.34%-587.49M

-36.86%-189.69M

Income tax

125.77%8.66M

134.84%13.45M

73.34%6.88M

-144.14%-69.51M

93.30%-1.26M

-87.89%-33.62M

-1,237.85%-38.6M

-17.91%3.97M

-611.96%-28.47M

-503.78%-18.8M

Net income

19.79%-106.65M

50.13%-99.18M

34.10%-91.58M

-12.09%-626.6M

8.83%-155.79M

-21.64%-132.97M

-30.77%-198.88M

-9.65%-138.96M

-6.70%-559.02M

-19.28%-170.89M

Net income continuous Operations

19.79%-106.65M

50.13%-99.18M

34.10%-91.58M

-12.09%-626.6M

8.83%-155.79M

-21.64%-132.97M

-30.77%-198.88M

-9.65%-138.96M

-6.70%-559.02M

-19.28%-170.89M

Minority interest income

Net income attributable to the parent company

19.79%-106.65M

50.13%-99.18M

34.10%-91.58M

-12.09%-626.6M

8.83%-155.79M

-21.64%-132.97M

-30.77%-198.88M

-9.65%-138.96M

-6.70%-559.02M

-19.28%-170.89M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

19.79%-106.65M

50.13%-99.18M

34.10%-91.58M

-12.09%-626.6M

8.83%-155.79M

-21.64%-132.97M

-30.77%-198.88M

-9.65%-138.96M

-6.70%-559.02M

-19.28%-170.89M

Basic earnings per share

21.02%-1.39

51.50%-1.29

36.17%-1.2

-7.45%-8.37

12.34%-2.06

-15.03%-1.76

-24.88%-2.66

-5.62%-1.88

-4.85%-7.79

-15.76%-2.35

Diluted earnings per share

21.02%-1.39

51.50%-1.29

36.17%-1.2

-7.45%-8.37

12.34%-2.06

-15.03%-1.76

-24.88%-2.66

-5.62%-1.88

-4.85%-7.79

-15.76%-2.35

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0.11%196.79M	-12.68%186.7M	-4.66%210.12M	34.20%937.82M	83.41%307.06M	-9.46%196.58M	29.17%213.81M	48.17%220.38M	29.75%698.8M	1.32%167.41M
Operating revenue	0.11%196.79M	-12.68%186.7M	-4.66%210.12M	34.20%937.82M	83.41%307.06M	-9.46%196.58M	29.17%213.81M	48.17%220.38M	29.75%698.8M	1.32%167.41M
Cost of revenue	14.27%10.85M	21.96%15.53M	4.21%14.74M	46.57%65.49M	167.31%29.12M	-32.25%9.49M	32.08%12.73M	39.56%14.14M	38.20%44.68M	16.79%10.89M
Gross profit	-0.61%185.94M	-14.87%171.18M	-5.27%195.38M	33.36%872.34M	77.57%277.94M	-7.89%187.08M	28.99%201.08M	48.80%206.24M	29.21%654.12M	0.40%156.52M
Operating expense	-21.68%237.9M	-36.42%204.53M	-25.05%240.93M	11.67%1.22B	-13.35%274.82M	9.81%303.75M	22.12%321.72M	35.74%321.45M	24.15%1.09B	25.50%317.18M
Selling and administrative expenses	-9.19%73.46M	-21.42%69.5M	-15.70%73.27M	2.01%332.54M	-17.72%76.29M	0.96%80.89M	10.71%88.45M	18.62%86.91M	14.08%326M	7.13%92.72M
Research and development costs	-1.71%161.41M	-28.89%132.17M	-40.48%116.13M	2.31%666.56M	-35.69%121.35M	-0.76%164.21M	18.19%185.87M	39.30%195.12M	20.49%651.5M	25.93%188.69M
Depreciation amortization depletion	-94.82%3.04M	-93.96%2.87M	30.74%51.53M	91.01%222.64M	115.79%77.17M	89.05%58.65M	80.26%47.4M	67.92%39.42M	112.88%116.55M	118.87%35.76M
-Depreciation and amortization	-94.82%3.04M	-93.96%2.87M	30.74%51.53M	91.01%222.64M	115.79%77.17M	89.05%58.65M	80.26%47.4M	67.92%39.42M	112.88%116.55M	118.87%35.76M
Operating profit	55.46%-51.97M	72.35%-33.36M	60.46%-45.55M	20.58%-349.4M	101.94%3.12M	-58.75%-116.66M	-12.16%-120.64M	-17.30%-115.22M	-17.33%-439.93M	-65.92%-160.66M
Net non-operating interest income expense	-47.76%-41.61M	-47.85%-43.49M	-49.41%-40.83M	-42.16%-129.18M	-80.71%-44.28M	-34.87%-28.16M	-33.85%-29.42M	-16.23%-27.33M	-5.64%-90.87M	-8.88%-24.5M
Non-operating interest expense	47.76%41.61M	47.85%43.49M	49.41%40.83M	42.16%129.18M	80.71%44.28M	34.87%28.16M	33.85%29.42M	16.23%27.33M	5.64%90.87M	8.88%24.5M
Other net income (expense)	79.71%-4.42M	89.84%-8.89M	-77.62%1.69M	-283.71%-217.53M	-2,455.03%-115.9M	33.72%-21.77M	-356.34%-87.42M	4,974.84%7.56M	1.19%-56.69M	76.47%-4.54M
Special income (charges)	-69.60%-2.54M	92.28%-6.86M	104.17%100K	-2,941.93%-227.66M	-239.83%-134.86M	-128.30%-1.5M	-684.87%-88.9M	-120.51%-2.4M	-1,596.80%-7.48M	-427.97%-39.68M
-Less：Restructuring and merger&acquisition	-53.33%700K	103.96%5.1M	-104.17%-100K	-393.05%-127.7M	-142.86%-2.7M	128.30%1.5M	-748.03%-128.9M	120.51%2.4M	-5,080.00%-25.9M	152.07%6.3M
-Less:Impairment of capital assets	--1.84M	-99.19%1.76M	----	552.41%217.8M	--0	--0	--217.8M	----	--33.38M	--33.38M
-Less:Other special charges	----	----	----	--137.56M	----	----	----	----	----	----
Other non- operating income (expenses)	90.76%-1.87M	-236.92%-2.03M	-84.02%1.59M	120.59%10.13M	-46.05%18.96M	46.87%-20.27M	104.30%1.48M	183.98%9.96M	14.98%-49.21M	212.02%35.15M
Income before tax	41.18%-97.99M	63.90%-85.73M	37.26%-84.7M	-18.49%-696.11M	17.21%-157.05M	-30.96%-166.59M	-59.71%-237.48M	-10.75%-134.99M	-13.34%-587.49M	-36.86%-189.69M
Income tax	125.77%8.66M	134.84%13.45M	73.34%6.88M	-144.14%-69.51M	93.30%-1.26M	-87.89%-33.62M	-1,237.85%-38.6M	-17.91%3.97M	-611.96%-28.47M	-503.78%-18.8M
Net income	19.79%-106.65M	50.13%-99.18M	34.10%-91.58M	-12.09%-626.6M	8.83%-155.79M	-21.64%-132.97M	-30.77%-198.88M	-9.65%-138.96M	-6.70%-559.02M	-19.28%-170.89M
Net income continuous Operations	19.79%-106.65M	50.13%-99.18M	34.10%-91.58M	-12.09%-626.6M	8.83%-155.79M	-21.64%-132.97M	-30.77%-198.88M	-9.65%-138.96M	-6.70%-559.02M	-19.28%-170.89M
Minority interest income
Net income attributable to the parent company	19.79%-106.65M	50.13%-99.18M	34.10%-91.58M	-12.09%-626.6M	8.83%-155.79M	-21.64%-132.97M	-30.77%-198.88M	-9.65%-138.96M	-6.70%-559.02M	-19.28%-170.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	19.79%-106.65M	50.13%-99.18M	34.10%-91.58M	-12.09%-626.6M	8.83%-155.79M	-21.64%-132.97M	-30.77%-198.88M	-9.65%-138.96M	-6.70%-559.02M	-19.28%-170.89M
Basic earnings per share	21.02%-1.39	51.50%-1.29	36.17%-1.2	-7.45%-8.37	12.34%-2.06	-15.03%-1.76	-24.88%-2.66	-5.62%-1.88	-4.85%-7.79	-15.76%-2.35
Diluted earnings per share	21.02%-1.39	51.50%-1.29	36.17%-1.2	-7.45%-8.37	12.34%-2.06	-15.03%-1.76	-24.88%-2.66	-5.62%-1.88	-4.85%-7.79	-15.76%-2.35
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data